お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は脂質代謝異常症市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは脂質代謝異常症の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の脂質代謝異常症市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは脂質代謝異常症のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に脂質代謝異常症市場を分類しています。本研究に含まれる主な企業は：Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Boehringer Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    OTC
    Rx Drugs

用途別の市場セグメント：
    Hospital
    Retail Pharmacy

本レポートの詳細内容
世界の脂質代謝異常症市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、脂質代謝異常症タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の脂質代謝異常症収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の脂質代謝異常症市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、脂質代謝異常症市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

脂質代謝異常症のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：脂質代謝異常症のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：脂質代謝異常症の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章脂質代謝異常症企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：脂質代謝異常症の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：脂質代謝異常症の主要企業の概要を提供し、製品の説明と仕様、脂質代謝異常症の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Lipid Metabolism Disease Drug is usually used to help lipid metabolism.

Market Analysis and Insights: Global Lipid Metabolism Disease Market
The global Lipid Metabolism Disease market is projected to grow from US$ 7702 million in 2024 to US$ 12150 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.
The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure.
Report Covers:
This report presents an overview of global market for Lipid Metabolism Disease market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Lipid Metabolism Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lipid Metabolism Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lipid Metabolism Disease revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Lipid Metabolism Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lipid Metabolism Disease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science, etc.

Market Segmentation
By Company
    Merck
    Novartis
    Takeda Pharmaceutical
    Astra Zeneca
    Boehringer Ingelheim
    KOWA
    Kythera
    Fuji yakuhin
    LG Life Science
    Metsubishi Tanabe Pharma

Segment by Type
    OTC
    Rx Drugs

Segment by Application
    Hospital
    Retail Pharmacy

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lipid Metabolism Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid Metabolism Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Metabolism Disease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Lipid Metabolism Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of OTC
    Table 3. Key Players of Rx Drugs
    Table 4. Global Lipid Metabolism Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Lipid Metabolism Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Lipid Metabolism Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Lipid Metabolism Disease Market Share by Region (2019-2024)
    Table 8. Global Lipid Metabolism Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Lipid Metabolism Disease Market Share by Region (2025-2030)
    Table 10. Lipid Metabolism Disease Market Trends
    Table 11. Lipid Metabolism Disease Market Drivers
    Table 12. Lipid Metabolism Disease Market Challenges
    Table 13. Lipid Metabolism Disease Market Restraints
    Table 14. Global Lipid Metabolism Disease Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Lipid Metabolism Disease Revenue Share by Players (2019-2024)
    Table 16. Global Top Lipid Metabolism Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Metabolism Disease as of 2023)
    Table 17. Global Lipid Metabolism Disease Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Lipid Metabolism Disease Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Lipid Metabolism Disease, Headquarters and Area Served
    Table 20. Global Key Players of Lipid Metabolism Disease, Product and Application
    Table 21. Global Key Players of Lipid Metabolism Disease, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Lipid Metabolism Disease Revenue Market Share by Type (2019-2024)
    Table 25. Global Lipid Metabolism Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Lipid Metabolism Disease Revenue Market Share by Type (2025-2030)
    Table 27. Global Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Lipid Metabolism Disease Revenue Share by Application (2019-2024)
    Table 29. Global Lipid Metabolism Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Lipid Metabolism Disease Revenue Share by Application (2025-2030)
    Table 31. North America Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Lipid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Lipid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Lipid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Lipid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Lipid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Lipid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Lipid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Lipid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Lipid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Lipid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Lipid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Lipid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Lipid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Lipid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Lipid Metabolism Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Lipid Metabolism Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Lipid Metabolism Disease Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Lipid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Merck Company Details
    Table 64. Merck Business Overview
    Table 65. Merck Lipid Metabolism Disease Product
    Table 66. Merck Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 67. Merck Recent Developments
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Lipid Metabolism Disease Product
    Table 71. Novartis Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 72. Novartis Recent Developments
    Table 73. Takeda Pharmaceutical Company Details
    Table 74. Takeda Pharmaceutical Business Overview
    Table 75. Takeda Pharmaceutical Lipid Metabolism Disease Product
    Table 76. Takeda Pharmaceutical Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 77. Takeda Pharmaceutical Recent Developments
    Table 78. Astra Zeneca Company Details
    Table 79. Astra Zeneca Business Overview
    Table 80. Astra Zeneca Lipid Metabolism Disease Product
    Table 81. Astra Zeneca Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 82. Astra Zeneca Recent Developments
    Table 83. Boehringer Ingelheim Company Details
    Table 84. Boehringer Ingelheim Business Overview
    Table 85. Boehringer Ingelheim Lipid Metabolism Disease Product
    Table 86. Boehringer Ingelheim Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 87. Boehringer Ingelheim Recent Developments
    Table 88. KOWA Company Details
    Table 89. KOWA Business Overview
    Table 90. KOWA Lipid Metabolism Disease Product
    Table 91. KOWA Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 92. KOWA Recent Developments
    Table 93. Kythera Company Details
    Table 94. Kythera Business Overview
    Table 95. Kythera Lipid Metabolism Disease Product
    Table 96. Kythera Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 97. Kythera Recent Developments
    Table 98. Fuji yakuhin Company Details
    Table 99. Fuji yakuhin Business Overview
    Table 100. Fuji yakuhin Lipid Metabolism Disease Product
    Table 101. Fuji yakuhin Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 102. Fuji yakuhin Recent Developments
    Table 103. LG Life Science Company Details
    Table 104. LG Life Science Business Overview
    Table 105. LG Life Science Lipid Metabolism Disease Product
    Table 106. LG Life Science Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 107. LG Life Science Recent Developments
    Table 108. Metsubishi Tanabe Pharma Company Details
    Table 109. Metsubishi Tanabe Pharma Business Overview
    Table 110. Metsubishi Tanabe Pharma Lipid Metabolism Disease Product
    Table 111. Metsubishi Tanabe Pharma Revenue in Lipid Metabolism Disease Business (2019-2024) & (US$ Million)
    Table 112. Metsubishi Tanabe Pharma Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lipid Metabolism Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Lipid Metabolism Disease Market Share by Type: 2023 VS 2030
    Figure 3. OTC Features
    Figure 4. Rx Drugs Features
    Figure 5. Global Lipid Metabolism Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Lipid Metabolism Disease Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Lipid Metabolism Disease Report Years Considered
    Figure 10. Global Lipid Metabolism Disease Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Lipid Metabolism Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Lipid Metabolism Disease Market Share by Region: 2023 VS 2030
    Figure 13. Global Lipid Metabolism Disease Market Share by Players in 2023
    Figure 14. Global Top Lipid Metabolism Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Metabolism Disease as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Lipid Metabolism Disease Revenue in 2023
    Figure 16. North America Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Lipid Metabolism Disease Market Share by Type (2019-2030)
    Figure 18. North America Lipid Metabolism Disease Market Share by Application (2019-2030)
    Figure 19. North America Lipid Metabolism Disease Market Share by Country (2019-2030)
    Figure 20. United States Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Lipid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Lipid Metabolism Disease Market Share by Type (2019-2030)
    Figure 24. Europe Lipid Metabolism Disease Market Share by Application (2019-2030)
    Figure 25. Europe Lipid Metabolism Disease Market Share by Country (2019-2030)
    Figure 26. Germany Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Lipid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Lipid Metabolism Disease Market Share by Type (2019-2030)
    Figure 34. China Lipid Metabolism Disease Market Share by Application (2019-2030)
    Figure 35. Asia Lipid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Lipid Metabolism Disease Market Share by Type (2019-2030)
    Figure 37. Asia Lipid Metabolism Disease Market Share by Application (2019-2030)
    Figure 38. Asia Lipid Metabolism Disease Market Share by Region (2019-2030)
    Figure 39. Japan Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Lipid Metabolism Disease Market Share by Country (2019-2030)
    Figure 49. Brazil Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Lipid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Merck Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 56. Novartis Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 58. Astra Zeneca Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 60. KOWA Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 61. Kythera Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 62. Fuji yakuhin Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 63. LG Life Science Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 64. Metsubishi Tanabe Pharma Revenue Growth Rate in Lipid Metabolism Disease Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed